Surrogate Endpoints and the Long Wait for Truth
A measurable proxy for a clinical outcome is a useful tool, until the field forgets that the proxy is not the outcome. Healthcare AI and longevity science have not yet…
Akkermansia muciniphila: How a Single Gut Microbe Became Longevity Science’s Most Studied Bacterium in 2026
Akkermansia muciniphila lives in the gut mucus layer and may be one of the most consequential microbes in longevity medicine. Inside the de Vos discovery, the Cani lab mechanism, the…
Zombie Cells Meet Their Match: How Natural Fatty Acids Could Become Longevity’s Most Promising New Weapon
Researchers at the University of Minnesota have identified naturally occurring fatty acids, specifically alpha-eleostearic acid and its methyl ester derivative, that selectively kill senescent zombie cells through ferroptosis. Published in…
The Grip Strength Signal: What 30 Years of Research Reveals About the Most Underrated Longevity Biomarker and How to Build It
A two dollar handheld dynamometer can predict mortality better than blood pressure in millions of people across 17 countries. Inside the Leong PURE cohort, the Saeidifard and Stamatakis meta-analyses, the…
The Polygenic Era: How Risk Scores Built From Millions of Genetic Variants Are Reshaping Preventive Medicine in 2026
For two decades after the Human Genome Project, the promise of personalized medicine outran the data. In 2026, that gap is finally closing. Polygenic risk scores built from millions of…
The NAD+ Question: What the Science Actually Shows About Longevity’s Most Hyped Supplement
The wellness industry is selling NAD+ pills and IV infusions as longevity interventions. On May 11, 2026, NPR asked what the science actually shows. We went deeper: tracing the biology,…
The Walking Cure: What a Decade of Step Count Research Reveals About the Most Underrated Longevity Tool in Modern Medicine
A 226,889 person meta-analysis, a 78,500 person UK Biobank study, and a decade of cohort work have transformed walking from a soft wellness recommendation into one of the most rigorously…
Beyond Weight Loss: The Mounting Evidence That GLP-1 Drugs May Be the First True Longevity Medications
A convergence of preclinical and clinical evidence , from a landmark Cell Metabolism mouse study to the first human epigenetic clock trial , is building the case that GLP-1 receptor…
The VO2 Max Imperative: What 50 Years of Research Reveal About the Strongest Mortality Predictor in Modern Medicine
A 122,007 patient JAMA Network Open study from the Cleveland Clinic showed that low cardiorespiratory fitness conferred a 5.04 fold higher all cause mortality risk than elite fitness, a larger…
The Forgotten Organ: How AI Just Revealed the Thymus as a Master Regulator of Longevity and Cancer Survival
Two landmark studies published in Nature used AI-powered deep learning to show that thymic health predicts longevity, cardiovascular risk, and cancer immunotherapy outcomes, rewriting decades of assumptions about adult biology…
